In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections. In Episode 4, the final segment, Jones offered his insights for when he considers discharging patients.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections. In Episode 3, Jones covers concerns around empirical antimicrobial treatment and opportunities to narrow down therapies.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections. In Episode 2, Jones offers clinical considerations for patient dosing and clinical management strategies associated with concurrent therapy.
In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections. In Episode 1, Jones discusses treating challenging patients with comorbidities such as type 2 diabetes, higher BMI, and advanced age.
Christian Sandrock, MD, MPH, FCCP, highlights key takeaways on approaching treatment of antimicrobial resistant gram-negative infections as presented in updated IDSA guidelines and ID week 2023.
George Sakoulas, MD, provides key insights on the management of soft tissue infections including the role of single-dose agents and treating patients in an outpatient setting.
An expert in infectious diseases shares treatment considerations and clinical strategies for the management of community acquired pneumonia (CAP).
COVID-19 reshaped the landscape of urinary tract infections (UTIs). Explore the prevalence of resistant pathogens, the impact on infection prevention, and the changes in positive pathogens.
What steps need taken to end viral hepatitis by 2030? “It all comes down to testing,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.
Our society’s criminalization of queerness, homelessness, and injection drug usage exacerbates HIV disease disparities. Joined by Steven Wolfe, DO, MPH, and Stuart A. Fisk, CRNP, of the Allegheny Health Network, we discuss the populations most at risk of HIV infection, as well as advice for making healthcare spaces more inclusive and accessible for LGBTQ+ people.
Although the development of antibiotics remains a challenge, there are some legislative strategies that could make it more attractive and get more players involved. On the fourth episode of the Contagion Community podcast, Evan Loh, MD, the CEO of Paratek Pharmaceuticals, discuses passing federal legislation to improve antibiotic development and reduce antimicrobial resistance.
People who use drugs face obstacles, like homelessness and stigma, that hinder their access to healthcare. Dr. Brianna Norton opened the Montefiore-NYHRE Clinic, a first-of its kind academic medical center, to serve marginalized people holistically and respectfully.
In this latest episode of Contagion Community, we interview Dr. Jacinda Abdul-Mutakabbir about vaccine equality vs vaccine equity as well as her experience on a COVID-19 vaccine drive to increase vaccinations in communities of color.
In this first episode of Contagion Community, we interview vaccine research scientist Dr. Leonard Friedland about vaccination disparities in the US and around the world.
A summary of today's top ID stories.
A summary of the day's top stories.